Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan

PURPOSE: The optimal treatment following endocrine therapy (ET) plus a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) has not been established. We aimed to investigate treatment patterns and time to treatment failure (TTF) of subsequent therapy after palbociclib in a Japanese real-world setting. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawaki, Masataka, Muramatsu, Yasuaki, Togo, Kanae, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248381/
https://www.ncbi.nlm.nih.gov/pubmed/37267715
http://dx.doi.org/10.1016/j.breast.2023.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248381/
https://www.ncbi.nlm.nih.gov/pubmed/37267715
http://dx.doi.org/10.1016/j.breast.2023.05.006

Ejemplares similares